Dr. Brandon Imber, MD, PhD
Claim this profileMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Area of expertise
Brain Tumor
Brandon Imber, MD, PhD has run 4 trials for Brain Tumor. Some of their research focus areas include:
Brain Cancer
Brandon Imber, MD, PhD has run 2 trials for Brain Cancer. Some of their research focus areas include:
Affiliated Hospitals
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Clinical Trials Brandon Imber, MD, PhD is currently running
Cs-131 Brachytherapy
for Recurrent Brain Cancer
The purpose of this study is to see if Cs-131 brachytherapy is effective in people with recurrent brain cancer who are scheduled to have brain surgery for removal of their tumor(s). The researchers would like to see whether Cs-131 prevents brain tumors from growing back after surgery.The researchers will compare Cs-131 brachytherapy (which occurs during brain surgery) with the usual approach of brain surgery without brachytherapy. The researchers will compare both the effectiveness and safety of the two approaches.
Recruiting
1 award
Phase 2
4 criteria
Bexarotene + Radiotherapy
for Cutaneous T-Cell Lymphoma
This trial tests the safety of combining bexarotene, a vitamin A derivative, with TSEB radiotherapy in patients with mycosis fungoides, a type of skin lymphoma. Bexarotene helps stop and kill cancer cells, while TSEB radiotherapy uses low-dose radiation to treat the skin. Researchers believe this combination may be more effective than using each treatment separately. Bexarotene has been used for both early and advanced cutaneous T-cell lymphoma (CTCL).
Recruiting
1 award
Phase 1
More about Brandon Imber, MD, PhD
Clinical Trial Related
5 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Brandon Imber, MD, PhD has experience with
- Radiation Therapy
- AZD1390
- GDC-0084
- Whole Brain Radiation Therapy
- PET Scan
- Radium Dichloride
Breakdown of trials Brandon Imber, MD, PhD has run
Brain Tumor
Brain Cancer
Leptomeningeal Neoplasms
Hereditary Sensory Neuropathy
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Brandon Imber, MD, PhD specialize in?
Brandon Imber, MD, PhD focuses on Brain Tumor and Brain Cancer. In particular, much of their work with Brain Tumor has involved Stage IV patients, or patients who are IDH positive.
Is Brandon Imber, MD, PhD currently recruiting for clinical trials?
Yes, Brandon Imber, MD, PhD is currently recruiting for 4 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Brandon Imber, MD, PhD has studied deeply?
Yes, Brandon Imber, MD, PhD has studied treatments such as Radiation Therapy, AZD1390, GDC-0084.
What is the best way to schedule an appointment with Brandon Imber, MD, PhD?
Apply for one of the trials that Brandon Imber, MD, PhD is conducting.
What is the office address of Brandon Imber, MD, PhD?
The office of Brandon Imber, MD, PhD is located at: Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center (All Protocol Activities).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.